National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis
Funds a Phase 0, I or II cancer trial that the investigator designed, inside one of six named National Cancer Institute programme areas.
The National Cancer Institute runs large trial networks, and this is the opposite of that: money for a trial an individual investigator thought of and wants to run.
The phases in scope are 0, I and II — first-in-human, dose-finding and early signal-seeking. The interventions have to be cancer-targeted and either diagnostic or therapeutic.
What makes or breaks an application here is fit with a pr…
Investigator-initiated Phase 0, I and II clinical trials of cancer-targeted diagnostic and therapeutic interventions, with at least one trial relevant to Cancer Therapy Evaluation, Cancer Imaging, Cancer Diagnosis, Radiation Research, Complementary and Alternative Medicine, or HIV and AIDS Malignancies research. Trials may stand alone or run alongside other aims.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up